Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...
Our capability statements summarise our experience and our impact on some of the world's most pressing development issues. Each statement outlines our approach and showcases the results and insights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback